跳至主要内容
临床试验/NCT03884647
NCT03884647已完成不适用

DELPHI Software for the Analysis of TMS-EEG Data of Brain Functionality - in Subjects at Risk for Stroke and Dementia

QuantalX Neuroscience4 个研究点 分布在 2 个国家目标入组 335 人开始时间: 2020年4月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
335
试验地点
4
主要终点
Establishing DELPhI's norms of population 50-75 years old at risk for stroke and dementia

研究概览

简要总结

The DELPhi system is a software device that is used for the noninvasive evaluation of brain plasticity and connectivity. The DELPhi software uses EEG and TMS devices as accessories. Standard electro-physiological acquisition is performed using TMS to evoke regional neuronal potentials measured as EEG data. TMS-EEG data is analyzed with regards to conventional, well established characteristics of neuronal network plasticity and connectivity.

详细描述

Transcranial magnetic stimulation (TMS) is a noninvasive brain stimulation method that allows to study human cortical function in vivo. Using TMS for examining human cortical functionality is enhanced by combining TMS with simultaneous registration of electroencephalograph (EEG). EEG provides an opportunity to directly measure the cerebral response to TMS. Measuring the cortical TMS Evoked potential (TEP), is used to assess cerebral reactivity across wide areas of neocortex.

By evaluating the propagation of evoked activity in different behavioral states and in different tasks, TMS-EEG has been used to causally probe the dynamic effective connectivity of human brain networks.

In this study the sponsor is intended to collect data of subjects at the ages of 50-75, at risk for stroke and dementia using DELPHI, brain MRI scans, cognitive tests and clinical and demographic information. Some of the patients agreeing to perform a second test will serve for a reliability test.

Primary Objectives:

  1. Definition of DELPHI's average TEP response of at risk for stroke and dementia population in subjects over 50-75 years old+/- STD.
  2. Assessing the Safey of the use of DELPHI in at risk for stroke and dementia population.
  3. Defining DELPHI's test-retest reliability by quantifying correlation coefficient between two tests.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
50 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Establishing DELPhI's norms of population 50-75 years old at risk for stroke and dementia

时间窗: 1 visit

Mean, STD, standard error (SEM), coefficient of variation (CV%), minimum, median, maximum and 95% confidence interval, for every DELPHI parameter in at risk for stroke and dementia population.

Establish DELPhI's safety in subjects 50-75 at risk for stroke and dementia.

时间窗: 1 week

Rates and Frequencies of Adverse events and descriptive report of Adverse events and possible relationship to DELPHI.

DELPHI's reliability

时间窗: 1 visit

Examining DELPHI's reliability by defining Intra-Class Correlation (ICC) coefficients between two tests performed at different days and/or different operators at each of DELPHI's parameters.

次要结局

未报告次要终点

研究者

发起方
QuantalX Neuroscience
申办方类型
Industry
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验